These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 9748745)

  • 1. [Regional chemotherapy in experimental cholangiocarcinoma in pigs].
    Dufek V; Petrtýl J
    Cas Lek Cesk; 1998 Aug; 137(15):464-6. PubMed ID: 9748745
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A phase II study of uracil-tegafur plus doxorubicin and prognostic factors in patients with unresectable biliary tract cancer.
    Furuse J; Okusaka T; Ohkawa S; Nagase M; Funakoshi A; Boku N; Yamao K; Yamaguchi T; Sato T
    Cancer Chemother Pharmacol; 2009 Dec; 65(1):113-20. PubMed ID: 19404641
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cholangiocarcinoma and the role of radiation and chemotherapy.
    Price P
    Hepatogastroenterology; 2001; 48(37):51-2. PubMed ID: 11268997
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hepatic arterial infusion of mitomycin C with degradable starch microspheres for unresectable intrahepatic cholangiocarcinoma.
    Shitara K; Ikami I; Munakata M; Muto O; Sakata Y
    Clin Oncol (R Coll Radiol); 2008 Apr; 20(3):241-6. PubMed ID: 18222071
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Arterial chemotherapy and conformal radiation abolish malignant biliary obstruction.
    Guan YS; Qing He ; Ping Li ; Fu YC; Zhao SW
    Integr Cancer Ther; 2008 Mar; 7(1):51-3. PubMed ID: 18292595
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [A case of intrahepatic bile duct cancer responding to 5-fluorouracil, adriamycin and mitomycin C chemotherapy].
    Uchiyama K; Takada T; Yasuda H; Hasegawa H; Tsuchiya S; Misu Y; Saitoh Y; Shikata J; Kozakai M
    Gan To Kagaku Ryoho; 1988 Jun; 15(6):1987-90. PubMed ID: 3132897
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Early phase II study of uracil-tegafur plus doxorubicin in patients with unresectable advanced biliary tract cancer.
    Furuse J; Okusaka T; Funakoshi A; Yamao K; Nagase M; Ishii H; Nakachi K; Ueno H; Ikeda M; Morizane C; Horikawa Y; Mizuno N
    Jpn J Clin Oncol; 2006 Sep; 36(9):552-6. PubMed ID: 16887837
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Chemotherapy for bile duct carcinoma in the light of adjuvant chemotherapy to surgery.
    Todoroki T
    Hepatogastroenterology; 2000; 47(33):644-9. PubMed ID: 10919004
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Photodynamic therapy for cholangiocarcinoma.
    Berr F
    Semin Liver Dis; 2004 May; 24(2):177-87. PubMed ID: 15192790
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Adrenal metastasis from intrahepatic cholangiocarcinoma.
    Pandey D; Lee KH; Wong SY; Tan KC
    Liver Int; 2007 Sep; 27(7):1016. PubMed ID: 17696942
    [No Abstract]   [Full Text] [Related]  

  • 11. [Good response in ARDS treated with sivelestat sodium hydrate during chemotherapy for cholangiocarcinoma].
    Hanada N; Kusano S; Hori K; Momi H
    Gan To Kagaku Ryoho; 2007 Aug; 34(8):1303-6. PubMed ID: 17687219
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Radiotherapy combined with transarterial infusion chemotherapy and concurrent infusion of a vasoconstrictor agent for nonresectable advanced hepatic hilar duct carcinoma.
    Matsumoto S; Kiyosue H; Komatsu E; Wakisaka M; Tomonari K; Hori Y; Matsumoto A; Mori H
    Cancer; 2004 Jun; 100(11):2422-9. PubMed ID: 15160347
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Successful treatment for advanced cholangiocellular carcinoma with intrahepatic metastasis and/or portal vein tumor thrombi by intraarterial chemotherapy combined with 5-fluorouracil, adriamycin and cisplatin (FAP)--two cases report].
    Wada H; Nagano H; Dono K; Kondo M; Yamamoto T; Ota H; Nakamura M; Yoshioka S; Damdinsuren B; Yubo Y; Marubashi S; Miyamoto A; Umeshita K; Nakamori S; Sakon M; Monden M
    Gan To Kagaku Ryoho; 2004 Oct; 31(11):1711-3. PubMed ID: 15553691
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Regional chemotherapy in biliary tract cancers--a single institution experience.
    Melichar B; Cerman J; Dvorák J; Jandík P; Mergancová J; Melicharová K; Tousková M; Krajina A; Voboril Z
    Hepatogastroenterology; 2002; 49(46):900-6. PubMed ID: 12143237
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Chemotherapy impregnated plastic biliary endoprostheses: one small step for man(agement) of cholangiocarcinoma.
    Baron TH
    Hepatology; 2000 Nov; 32(5):1170-1. PubMed ID: 11050071
    [No Abstract]   [Full Text] [Related]  

  • 16. Patients with advanced cholangiocarcinoma benefit from chemotherapy if they are fit to receive it: single center experience.
    Kose F; Abali H; Sezer A; Ali Besen A; Taner Sumbul A; Karadeniz C; Disel U; Ozyilkan U
    J BUON; 2011; 16(3):469-72. PubMed ID: 22006752
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cholangiocarcinoma: the impact of tumor location and treatment strategy on outcome.
    Heron DE; Stein DE; Eschelman DJ; Topham AK; Waterman FM; Rosato EL; Alden M; Anne PR
    Am J Clin Oncol; 2003 Aug; 26(4):422-8. PubMed ID: 12902899
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Unresectable hilar cholangiocarcinoma: multimodality approach with percutaneous treatment associated with radiotherapy and chemotherapy.
    Golfieri R; Giampalma E; Renzulli M; Galuppi A; Vicenzi L; Galaverni MC; Cappelli A
    In Vivo; 2006; 20(6A):757-60. PubMed ID: 17203762
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Time to move to targeted drugs in biliary tract cancer?
    Louvet C; Tournigand C
    Onkologie; 2010; 33(1-2):10-1. PubMed ID: 20164655
    [No Abstract]   [Full Text] [Related]  

  • 20. Influence of age on surgical treatment of peripheral cholangiocarcinoma.
    Yeh CN; Jan YY; Chen MF
    Am J Surg; 2004 Apr; 187(4):559-63. PubMed ID: 15041513
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.